tirzepatide february 2025 Compounded GLP-1 Ban: What I Know So Far Eli Lilly has launched new

Description

I think those are questions that we don't have the answers for yet. Most of the kids and teens getting these drugs are girls Among adolescents aged 12-17, girls received 60% of prescriptions between 2020 and 2023, and young women received 76% of the prescriptions for adults aged 18-25

Government data released in March 2025 shows 24 per cent of women and 23 per cent of men are overweight or obese in India

four-week steps are the tolerability buffer, and skipping them is the top cause of severe side effects

No worsening of spinal CSF leak symptoms : Given the research I recap below about intracranial hypertension and use of GLP-1RAs to lower intracranial pressure, I was very concerned that this class of medication could worsen my spinal CSF leak symptoms

6.6 Effects on renal functions The result of clinical trials of tirzepatide on kidney function indicates potential renal advantages, especially in individuals with type-2 diabetes (T2D) and a heightened cardiovascular risk.In the SURPASS-4 (NCT03730662) trial, tirzepatide was observed to reduce occurrence of the composite kidney endpoint (like eGFR decline of at least 40% from baseline, end-stage kidney disease, death due to kidney failure, or new-onset macro albuminuria) in comparison to those receiving insulin glargine